Auxly Cannabis Group Ausschüttungen und Rückkäufe

Zukünftiges Wachstum Kriterienprüfungen 0/6

Auxly Cannabis Group hat in der Vergangenheit keine Dividende gezahlt.

Wichtige Informationen

n/a

Dividendenausschüttung

-6.3%

Rückkaufsrendite

Gesamte Aktionärsrendite-6.3%
Zukünftige Dividendenrenditen/a
Wachstum der Dividenden/a
Nächster Dividendenzahlungsterminn/a
Ex-Dividendendatumn/a
Dividende pro Aktien/a
Ausschüttungsquoten/a

Jüngste Updates zu Dividenden und Rückkäufen

Keine Aktualisierungen

Recent updates

Investors Still Aren't Entirely Convinced By Auxly Cannabis Group Inc.'s (TSE:XLY) Revenues Despite 43% Price Jump

Nov 03
Investors Still Aren't Entirely Convinced By Auxly Cannabis Group Inc.'s (TSE:XLY) Revenues Despite 43% Price Jump

Is Auxly Cannabis Group (TSE:XLY) A Risky Investment?

Oct 02
Is Auxly Cannabis Group (TSE:XLY) A Risky Investment?

Auxly Cannabis Group Inc.'s (TSE:XLY) Shares Leap 60% Yet They're Still Not Telling The Full Story

Aug 09
Auxly Cannabis Group Inc.'s (TSE:XLY) Shares Leap 60% Yet They're Still Not Telling The Full Story

Market Cool On Auxly Cannabis Group Inc.'s (TSE:XLY) Revenues Pushing Shares 40% Lower

Jun 19
Market Cool On Auxly Cannabis Group Inc.'s (TSE:XLY) Revenues Pushing Shares 40% Lower

Does Auxly Cannabis Group (TSE:XLY) Have A Healthy Balance Sheet?

Apr 27
Does Auxly Cannabis Group (TSE:XLY) Have A Healthy Balance Sheet?

A Piece Of The Puzzle Missing From Auxly Cannabis Group Inc.'s (TSE:XLY) 33% Share Price Climb

Mar 21
A Piece Of The Puzzle Missing From Auxly Cannabis Group Inc.'s (TSE:XLY) 33% Share Price Climb

Auxly Cannabis Group Inc. (TSE:XLY) Stock Rockets 33% But Many Are Still Ignoring The Company

Feb 03
Auxly Cannabis Group Inc. (TSE:XLY) Stock Rockets 33% But Many Are Still Ignoring The Company

Take Care Before Jumping Onto Auxly Cannabis Group Inc. (TSE:XLY) Even Though It's 38% Cheaper

Dec 19
Take Care Before Jumping Onto Auxly Cannabis Group Inc. (TSE:XLY) Even Though It's 38% Cheaper

Does Auxly Cannabis Group (TSE:XLY) Have A Healthy Balance Sheet?

Oct 17
Does Auxly Cannabis Group (TSE:XLY) Have A Healthy Balance Sheet?

Is Auxly Cannabis Group (TSE:XLY) Using Debt In A Risky Way?

Jul 14
Is Auxly Cannabis Group (TSE:XLY) Using Debt In A Risky Way?

Auxly Cannabis Group Inc. (TSE:XLY) Could Be Riskier Than It Looks

Apr 17
Auxly Cannabis Group Inc. (TSE:XLY) Could Be Riskier Than It Looks

The Consensus EPS Estimates For Auxly Cannabis Group Inc. (TSE:XLY) Just Fell Dramatically

Aug 11
The Consensus EPS Estimates For Auxly Cannabis Group Inc. (TSE:XLY) Just Fell Dramatically

Health Check: How Prudently Does Auxly Cannabis Group (TSE:XLY) Use Debt?

Jul 21
Health Check: How Prudently Does Auxly Cannabis Group (TSE:XLY) Use Debt?

Growth Investors: Industry Analysts Just Upgraded Their Auxly Cannabis Group Inc. (TSE:XLY) Revenue Forecasts By 8.2%

Aug 18
Growth Investors: Industry Analysts Just Upgraded Their Auxly Cannabis Group Inc. (TSE:XLY) Revenue Forecasts By 8.2%

Auxly Cannabis Group Inc. (TSE:XLY) Just Reported And Analysts Have Been Cutting Their Estimates

Apr 29
Auxly Cannabis Group Inc. (TSE:XLY) Just Reported And Analysts Have Been Cutting Their Estimates

Breakeven On The Horizon For Auxly Cannabis Group Inc. (CVE:XLY)

Mar 24
Breakeven On The Horizon For Auxly Cannabis Group Inc. (CVE:XLY)

A Look At Auxly Cannabis Group's (CVE:XLY) Share Price Returns

Jan 28
A Look At Auxly Cannabis Group's (CVE:XLY) Share Price Returns

Stabilität und Wachstum des Zahlungsverkehrs

Rufe Dividendendaten ab

Stabile Dividende: Es liegen keine ausreichenden Daten vor, um festzustellen, ob die Dividende je Aktie von XLY in der Vergangenheit stabil war.

Wachsende Dividende: Unzureichende Daten, um festzustellen, ob die Dividendenzahlungen von XLY gestiegen sind.


Dividendenrendite im Vergleich zum Markt

Auxly Cannabis Group Dividendenrendite im Vergleich zum Markt
Wie sieht die Dividendenrendite von XLY im Vergleich zum Markt aus?
SegmentDividendenrendite
Unternehmen (XLY)n/a
Untere 25 % des Marktes (CA)1.8%
Markt Top 25 % (CA)6.1%
Branchendurchschnitt (Pharmaceuticals)2.5%
Analystenprognose (XLY) (bis zu 3 Jahre)n/a

Bemerkenswerte Dividende: Es ist nicht möglich, die Dividendenrendite von XLY im Vergleich zu den unteren 25 % der Dividendenzahler zu bewerten, da das Unternehmen keine aktuellen Ausschüttungen gemeldet hat.

Hohe Dividende: Es ist nicht möglich, die Dividendenrendite von XLY im Vergleich zu den besten 25 % der Dividendenzahler zu bewerten, da das Unternehmen keine aktuellen Ausschüttungen gemeldet hat.


Gewinnausschüttung an die Aktionäre

Abdeckung der Erträge: Unzureichende Daten zur Berechnung der Ausschüttungsquote von XLY, um festzustellen, ob die Dividendenzahlungen durch die Gewinne gedeckt sind.


Barausschüttung an die Aktionäre

Cashflow-Deckung: Es ist nicht möglich, die Nachhaltigkeit der Dividende zu berechnen, da XLY keine Ausschüttungen gemeldet hat.


Entdecken Sie dividendenstarke Unternehmen